If additional glycaemic control is needed after at least 4 weeks, the dose may be increased to 1 mg or 2 mg weekly, as clinically indicated
However, for the 2008 survey, we changed the structure of the question and now include separate annual deductible or hospital admissions as a response option rather than collecting the information through a separate question
Important Notice: The GLP-1 Collective is a 501(c)(3) nonprofit organization
The patient has established cardiovascular disease with a documented history of at least one of the following: A) Previous myocardial infarction (MI) B) Previous stroke C) Symptomatic peripheral arterial disease (PAD), evidenced by one of the following: Intermittent claudication with an ankle-brachial index (ABI) less than 0.85 at rest Peripheral arterial revascularization procedure Amputation due to atherosclerotic disease D) Prior revascularization, such as coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or angioplasty, and
Hemoglobin is the protein in red blood cells that enables oxygen to travel around the body
